Related Experiment Videos
Eosinophilic fasciitis: a mast cell disorder?
Clinical and Experimental Rheumatology
|January 1, 1983
Summary
Eosinophilic fasciitis, a rare condition, may involve mast cells and Sezary-like cells, not eosinophils. Early steroid treatment appears beneficial for managing this rare fasciitis.
Area of Science:
- Rheumatology
- Dermatology
- Pathology
Background:
- Eosinophilic fasciitis (EF) is a rare connective tissue disease characterized by inflammation of the fascia.
- The etiology and precise nosographical classification of EF remain undefined due to its rarity, hindering systematic research.
- Limited case studies underscore the need for further investigation into EF's pathogenesis and clinical presentation.
Observation:
- A unique case of eosinophilic fasciitis presented with gradual onset, concurrent with allergic bronchial asthma.
- Histopathological examination revealed an absence of eosinophils but a significant presence of degranulating mast cells and Sezary-like cells in the affected fascia.
- These distinctive features challenge the typical understanding of EF's cellular infiltrate.
Findings:
- The case highlights atypical cellular findings in eosinophilic fasciitis, emphasizing mast cell and Sezary-like cell involvement.
- Absence of eosinophils in this case suggests potential heterogeneity in EF pathogenesis.
- The simultaneous occurrence with allergic bronchial asthma may indicate an underlying systemic inflammatory or allergic link.
Implications:
- The findings suggest that early corticosterosteroid therapy may be a crucial intervention for patients presenting with these specific features of eosinophilic fasciitis.
- Further research is warranted to explore the role of mast cells and Sezary-like cells in EF and to define diagnostic criteria.
- This case contributes to the understanding of rare autoimmune and inflammatory conditions, potentially refining diagnostic and therapeutic strategies for eosinophilic fasciitis.